Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months
B Ejlertsen, P Pfeiffer, D Pedersen, H T Mouridsen, C Rose, M Overgaard, E Sandberg, B Kristensen
Fingerprint
Dive into the research topics of 'Decreased efficacy of cyclophosphamide, epirubicin and 5-fluorouracil in metastatic breast cancer when reducing treatment duration from 18 to 6 months'. Together they form a unique fingerprint.